Moneycontrol PRO
HomeNewsGrand slam asset management

Grand Slam Asset Management

Jump to
  • Sun Pharma, Taro terminate merger deal

    Taro Pharmaceutical and Sun Pharma have mutually agreed to terminate their merger agreement, announced in August 2012, reports CNBC-TV18's Archana Shukla.

  • Sun's merger plans: Taro's shareholders may play spoilsport

    The Sun Pharma stock rallied 3% today after the drug-maker offered to acquire 100% in the Israeli drug-firm Taro Pharma in which it has 66% stake. While the move got a thumbs-up from analysts, some of Taro’s large shareholders may play spoilsport, reports CNBC-TV18's Archana Shukla.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347